Reid Olsen is an accomplished GPCR pharmacologist and project lead, specializing in neuroscience, neurobiology, and molecular pharmacology. They co-invented the TRUPATH GPCR screening platform and have contributed significantly to drug discovery technologies. Currently serving as the Director of Strategic Drug Discovery Initiatives at Recursion, Reid oversees GPCR-focused preclinical drug discovery programs. Previously, they held leadership roles at Exscientia, focusing on integrating biological data with computational models to enhance therapeutic development. Reid earned a Ph.D. in Pharmacology from the University of North Carolina at Chapel Hill, where they authored multiple scientific publications and developed innovative research tools.
This person is not in any teams
This person is not in any offices